XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Equity
 9 Months Ended
May 29, 2025
Equity [Abstract]  
Equity
Equity

Common Stock Repurchases

Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions, restrictions applicable under our CHIPS Act direct funding agreements, and our ongoing determination of the best use of available cash. See “Item 1. Financial Statements – Notes to Consolidated Financial Statements – CHIPS Act Funding Agreements.” No shares were repurchased in the first nine months of 2025. Through May 29, 2025, we had repurchased an aggregate of $7.19 billion under the authorization. Amounts repurchased are included in treasury stock.

Dividends

We declared and paid dividends of $0.115 per share in the first, second, and third quarters of 2025. On June 25, 2025, our Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on July 22, 2025, to shareholders of record as of the close of business on July 7, 2025.

Accumulated Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income (loss) by component for the nine months ended May 29, 2025 were as follows:
Gains (Losses) on Derivative InstrumentsUnrealized Gains (Losses) on InvestmentsPension Liability AdjustmentsCumulative Foreign Currency Translation AdjustmentTotal
As of August 29, 2024$(162)$(8)$39 $(3)$(134)
Other comprehensive income (loss) before reclassifications
38 (2)— — 36 
Amount reclassified out of accumulated other comprehensive income (loss)
106 (1)(2)— 103 
Tax effects
(51)— 1 — (50)
Other comprehensive income (loss)93 (3)(1)— 89 
As of May 29, 2025$(69)$(11)$38 $(3)$(45)